Neurosciences News

WAIKOLOA, Hawaii — At Hawaiian Eye, Andrew G. Lee, MD, discusses neuro-ophthalmology as an "ophthalmic superpower," which enables ophthalmologists to home in on life- and vision-threatening neuro-ophthalmic conditions by assessing the patient's pupil.

WAIKOLOA, Hawaii — Andrew G. Lee, MD, chairman of ophthalmology at Blanton Eye Institute at Houston Methodist Hospital, Texas, was named Speaker of the Day for the Comprehensive Ophthalmology Program for his panel discussion with Randy H. Kardon, MD, PhD, and Grant T. Liu, MD, on neuro-ophthalmology case reviews, as well as Speaker of the Day for the Nurse & Allied Health Program for his talk on neuro-ophthalmology.

At the OSN New York 2015 meeting, Andrew G. Lee, MD, gives an overview on this year's trends in neuro-ophthalmology.

LAS VEGAS — OCT is increasingly useful in diagnosing disorders that affect optical pathways to the brain, a speaker told colleagues.

A 72-year-old Armenian woman was referred to the oculoplastics clinic at the New England Eye Center for evaluation of bilateral ptosis. She noticed gradual onset of drooping eyelids over the course of many years.

A previously healthy 19-year-old college student was referred to the New England Eye Center for evaluation after returning from Indonesia where she had studied abroad and suffered a severe illness requiring hospitalization. She had blurred vision in both eyes, photophobia and a blind spot in the center of her vision. Her ocular history was notable only for congenital coloboma in her right eye, and she was on no medications. She had never smoked cigarettes or used drugs, and she drank beer and liquor occasionally with friends.

The FDA has announced that there are potential vision loss risks because of pigment changes in the retina and possible skin discoloration for patients treated with the anti-seizure drug Potiga, according to reviews of additional safety data.

A 6-year-old boy was referred to the New England Eye Center with symptoms of intermittent headaches for the last 3 months. The patient and his mother described the headaches as occurring three to four times per week, located primarily frontal and “on top of the head,” that would become progressively severe, lasting 1 to 2 hours, occasionally associated with nausea. Initially, it was thought the headaches may be related to concentrated activities such as reading. However, the pain was now occurring more often without any notable aggravating factors.

An 88-year-old woman was referred urgently by rheumatology to our neuro-ophthalmology clinic due to “going blind” in her left eye starting 3 weeks before presentation in the setting of very prominent temporal arteries. She reported that her vision loss was sudden and painless and that it did not fluctuate after the initial drastic decline. She denied any prior transient vision loss, diplopia, other visual disturbances or trauma. She denied any associated headaches, fevers, chills, night sweats, jaw claudication, scalp tenderness or proximal muscle weakness. She denied any visual disturbances in her right eye.

An 88-year-old woman was referred urgently by rheumatology to our neuro-ophthalmology clinic due to “going blind” in her left eye starting 3 weeks before presentation in the setting of very prominent temporal arteries. She reported that her vision loss was sudden and painless and that it did not fluctuate after the initial drastic decline. She denied any prior transient vision loss, diplopia, other visual disturbances or trauma. She denied any associated headaches, fevers, chills, night sweats, jaw claudication, scalp tenderness or proximal muscle weakness. She denied any visual disturbances in her right eye.